a provider of multiple insurance and investment management products
Industry LifeHealthInsurance
This price move could indicate a change in the trend, and may be a buy signal for investors. A.I.dvisor found 51 similar cases, and were successful. Based on this data, the odds of success are
The RSI Indicator for LNC moved out of oversold territory on October 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 22 of the 26 cases the stock moved higher. This puts the odds of a move higher at 85%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on LNC as a result. In 69 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for LNC just turned positive on October 21, 2026. Looking at past instances where LNC's MACD turned positive, the stock continued to rise in 31 of 45 cases over the following month. The odds of a continued upward trend are 69%.
Following a +2.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where LNC advanced for three days, in 237 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LNC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for LNC entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.758) is normal, around the industry mean (1.339). P/E Ratio (3.384) is within average values for comparable stocks, (19.975). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (0.463). Dividend Yield (0.044) settles around the average of (0.048) among similar stocks. P/S Ratio (0.427) is also within normal values, averaging (1.303).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. LNC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LNC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock worse than average.